{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:51:36Z","timestamp":1791827496292,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianfu Emei Program","award":["CW202204"],"award-info":[{"award-number":["CW202204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02806-1","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:06:14Z","timestamp":1791813974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of diabetes-related clinical indices in patients with non-small cell lung cancer and comorbid type 2 diabetes receiving immune checkpoint inhibitor therapy"],"prefix":"10.1007","author":[{"given":"Qiang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoshu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangkai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-6179","authenticated-orcid":false,"given":"Yuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"3","key":"2806_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2806_CR2","doi-asserted-by":"crossref","unstructured":"Zhou F, Zhao W, Gong X et al (2020) Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer. J Immunother Cancer. ;8(2)","DOI":"10.1136\/jitc-2020-001300"},{"issue":"4","key":"2806_CR3","first-page":"Cd013257","volume":"4","author":"R Ferrara","year":"2021","unstructured":"Ferrara R, Imbimbo M, Malouf R et al (2021) Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer. Cochrane Database Syst Rev 4(4):Cd013257","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2806_CR4","doi-asserted-by":"publisher","first-page":"e246837","DOI":"10.1001\/jamanetworkopen.2024.6837","volume":"7","author":"GL Banna","year":"2024","unstructured":"Banna GL, Hassan MA, Signori A et al (2024) Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open 7(4):e246837","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2806_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","volume":"19","author":"F Conforti","year":"2018","unstructured":"Conforti F, Pala L, Bagnardi V et al (2018) Cancer immunotherapy efficacy and patients\u2019 sex: a systematic review and meta-analysis. Lancet Oncol 19(6):737\u2013746","journal-title":"Lancet Oncol"},{"issue":"1","key":"2806_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12916-022-02444-8","volume":"20","author":"J Zhou","year":"2022","unstructured":"Zhou J, Bao M, Gao G et al (2022) Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer. BMC Med 20(1):256","journal-title":"BMC Med"},{"issue":"6","key":"2806_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.neo.2021.05.005","volume":"23","author":"S M\u00fcller","year":"2021","unstructured":"M\u00fcller S, Mayer S, M\u00f6ller P et al (2021) Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinoma. Neoplasia 23(6):584\u2013593","journal-title":"Neoplasia"},{"issue":"3","key":"2806_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1164\/rccm.201704-0795OC","volume":"197","author":"NM Mark","year":"2018","unstructured":"Mark NM, Kargl J, Busch SE et al (2018) Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer. Am J Respir Crit Care Med 197(3):325\u2013336","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2806_CR9","doi-asserted-by":"publisher","first-page":"2469375","DOI":"10.1080\/2162402X.2025.2469375","volume":"14","author":"A Greib","year":"2025","unstructured":"Greib A, Zhao S, Ploch M et al (2025) Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients. Oncoimmunology 14(1):2469375","journal-title":"Oncoimmunology"},{"issue":"1","key":"2806_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s12885-021-08272-y","volume":"21","author":"D Zhu","year":"2021","unstructured":"Zhu D, Ding R, Ma Y et al (2021) Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China. BMC Cancer 21(1):557","journal-title":"BMC Cancer"},{"key":"2806_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.lungcan.2018.10.002","volume":"125","author":"D Jegou","year":"2018","unstructured":"Jegou D, Dubois C, Schillemans V et al (2018) Use of health insurance data to identify and quantify the prevalence of main comorbidities in lung cancer patients. Lung Cancer 125:238\u2013244","journal-title":"Lung Cancer"},{"issue":"7","key":"2806_CR12","doi-asserted-by":"publisher","first-page":"e17969","DOI":"10.1016\/j.heliyon.2023.e17969","volume":"9","author":"A Leiter","year":"2023","unstructured":"Leiter A, Stephens C, Mhango G et al (2023) Impact of diabetes on stage I lung cancer treatment patterns and prognosis in older adults: A population-based cohort study. Heliyon 9(7):e17969","journal-title":"Heliyon"},{"key":"2806_CR13","doi-asserted-by":"publisher","first-page":"115303","DOI":"10.1016\/j.ejca.2025.115303","volume":"218","author":"M Borg","year":"2025","unstructured":"Borg M, L\u00f8kke A, Ibsen R et al (2025) Four decades of lung cancer: Trends in comorbidities and causes of death in a nationwide Danish cohort. Eur J Cancer 218:115303","journal-title":"Eur J Cancer"},{"issue":"9","key":"2806_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1159\/000516671","volume":"99","author":"O Jacobi","year":"2021","unstructured":"Jacobi O, Landman Y, Reinhorn D et al (2021) The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer. Oncology 99(9):555\u2013561","journal-title":"Oncology"},{"key":"2806_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/DMSO.S289446","volume":"14","author":"K Hisanaga","year":"2021","unstructured":"Hisanaga K, Uchino H, Kakisu N et al (2021) Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan. Diabetes Metab Syndr Obes 14:773\u2013781","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2806_CR16","doi-asserted-by":"publisher","first-page":"111930","DOI":"10.1016\/j.diabres.2024.111930","volume":"218","author":"NN Nguyen","year":"2024","unstructured":"Nguyen NN, Ha Nguyen TH, Hoang KD et al (2024) The prognostic significance of diabetes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis. Diabetes Res Clin Pract 218:111930","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2806_CR17","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1186\/s12885-021-08801-9","volume":"21","author":"M Niksic","year":"2021","unstructured":"Niksic M, Redondo-Sanchez D, Chang YL et al (2021) The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study. BMC Cancer 21(1):1048","journal-title":"BMC Cancer"},{"issue":"1","key":"2806_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1158\/1055-9965.EPI-24-0833","volume":"34","author":"AM Noone","year":"2025","unstructured":"Noone AM, Mariotto AB, Hong YD et al (2025) Assessing 1-Year Comorbidity Prevalence and Its Survival Implications in Medicare Beneficiaries Diagnosed with Cancer: Insights from a New SEER-Medicare Resource. Cancer Epidemiol Biomarkers Prev 34(1):182\u2013189","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2806_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1471-2407-12-174","volume":"12","author":"SH Shieh","year":"2012","unstructured":"Shieh SH, Probst JC, Sung FC et al (2012) Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes. BMC Cancer 12:174","journal-title":"BMC Cancer"},{"issue":"4","key":"2806_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.32604\/or.2022.027262","volume":"30","author":"D Hernandez","year":"2022","unstructured":"Hernandez D, Cheng CY, Hernandez-Villafuerte K et al (2022) Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany. Oncol Res 30(4):173\u2013185","journal-title":"Oncol Res"},{"issue":"2","key":"2806_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11(2):98\u2013107","journal-title":"Nat Rev Immunol"},{"key":"2806_CR22","doi-asserted-by":"crossref","unstructured":"Petrelli A, Thomas NJ, Hope SV et al (2026) Pathophysiology and treatment of type 1 diabetes in older adults. Diabetes Care","DOI":"10.2337\/dci25-0143"},{"issue":"8","key":"2806_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s40618-017-0641-y","volume":"40","author":"D Frumento","year":"2017","unstructured":"Frumento D, Ben Nasr M, El Essawy B et al (2017) Immunotherapy for type 1 diabetes. J Endocrinol Invest 40(8):803\u2013814","journal-title":"J Endocrinol Invest"},{"key":"2806_CR24","doi-asserted-by":"publisher","first-page":"259341","DOI":"10.1155\/2015\/259341","volume":"2015","author":"SJ Yoon","year":"2015","unstructured":"Yoon SJ, Kim EJ, Seo HJ et al (2015) The Association between Charlson Comorbidity Index and the Medical Care Cost of Cancer: A Retrospective Study. Biomed Res Int 2015:259341","journal-title":"Biomed Res Int"},{"issue":"2","key":"2806_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.lungcan.2013.08.011","volume":"82","author":"D Ball","year":"2013","unstructured":"Ball D, Thursfield V, Irving L et al (2013) Evaluation of the Simplified Comorbidity Score (Colinet) as a prognostic indicator for patients with lung cancer: a cancer registry study. Lung Cancer 82(2):358\u2013361","journal-title":"Lung Cancer"},{"issue":"3","key":"2806_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s44197-022-00044-6","volume":"12","author":"K Lee","year":"2022","unstructured":"Lee K, Kang S, Hwang J (2022) Lung Cancer Patients\u2019 Characteristics and Comorbidities Using the Korean National Hospital Discharge In-depth Injury Survey Data. J Epidemiol Glob Health 12(3):258\u2013266","journal-title":"J Epidemiol Glob Health"},{"issue":"4","key":"2806_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC et al (2016) Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"issue":"4","key":"2806_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16(4):385\u2013395","journal-title":"Stat Med"},{"issue":"11","key":"2806_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v050.i11","volume":"50","author":"UB Mogensen","year":"2012","unstructured":"Mogensen UB, Ishwaran H, Gerds TA (2012) Evaluating Random Forests for Survival Analysis using Prediction Error Curves. J Stat Softw 50(11):1\u201323","journal-title":"J Stat Softw"},{"issue":"21","key":"2806_CR30","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.7150\/jca.30528","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Ding M, Duan X et al (2019) Diagnostic Value of Plasma MicroRNAs for Lung Cancer Using Support Vector Machine Model. J Cancer 10(21):5090\u20135098","journal-title":"J Cancer"},{"key":"2806_CR31","doi-asserted-by":"publisher","first-page":"655686","DOI":"10.3389\/fmed.2021.655686","volume":"8","author":"Q Xue","year":"2021","unstructured":"Xue Q, Wen D, Ji MH et al (2021) Developing Machine Learning Algorithms to Predict Pulmonary Complications After Emergency Gastrointestinal Surgery. Front Med (Lausanne) 8:655686","journal-title":"Front Med (Lausanne)"},{"issue":"6371","key":"2806_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R et al (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371):104\u2013108","journal-title":"Science"},{"issue":"1","key":"2806_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","volume":"14","author":"M Delamaire","year":"1997","unstructured":"Delamaire M, Maugendre D, Moreno M et al (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14(1):29\u201334","journal-title":"Diabet Med"},{"issue":"3","key":"2806_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/mgme.2001.3185","volume":"73","author":"MA Mazade","year":"2001","unstructured":"Mazade MA, Edwards MS (2001) Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol Genet Metab 73(3):259\u2013267","journal-title":"Mol Genet Metab"},{"issue":"9","key":"2806_CR35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2337\/diabetes.49.9.1451","volume":"49","author":"SN Zykova","year":"2000","unstructured":"Zykova SN, Jenssen TG, Berdal M et al (2000) Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db\/db mice. Diabetes 49(9):1451\u20131458","journal-title":"Diabetes"},{"issue":"6b","key":"2806_CR36","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/j.1582-4934.2009.00803.x","volume":"14","author":"CL Price","year":"2010","unstructured":"Price CL, Hassi HO, English NR et al (2010) Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med 14(6b):1806\u20131815","journal-title":"J Cell Mol Med"},{"issue":"11","key":"2806_CR37","doi-asserted-by":"publisher","first-page":"eadd8564","DOI":"10.1126\/sciadv.add8564","volume":"9","author":"L Vornholz","year":"2023","unstructured":"Vornholz L, Isay SE, Kurgyis Z et al (2023) Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy. Sci Adv 9(11):eadd8564","journal-title":"Sci Adv"},{"issue":"12","key":"2806_CR38","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.4251\/wjgo.v13.i12.1997","volume":"13","author":"A Rojas","year":"2021","unstructured":"Rojas A, Lindner C, Schneider I et al (2021) Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer. World J Gastrointest Oncol 13(12):1997\u20132012","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"2806_CR39","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-19-1623","volume":"29","author":"R Peila","year":"2020","unstructured":"Peila R, Rohan TE, Diabetes (2020) Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study. Cancer Epidemiol Biomarkers Prev 29(6):1107\u20131119","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2806_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3892\/mco.2014.289","volume":"2","author":"M Zhang","year":"2014","unstructured":"Zhang M, Li X, Zhang X et al (2014) Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer. Mol Clin Oncol 2(4):506\u2013508","journal-title":"Mol Clin Oncol"},{"issue":"22","key":"2806_CR41","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1111\/1759-7714.14174","volume":"12","author":"M Kong","year":"2021","unstructured":"Kong M, Lim YJ (2021) Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non-small cell lung cancer patients treated with radiotherapy. Thorac Cancer 12(22):3032\u20133038","journal-title":"Thorac Cancer"},{"issue":"5","key":"2806_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00595-017-1612-9","volume":"48","author":"M Motoishi","year":"2018","unstructured":"Motoishi M, Sawai S, Hori T et al (2018) The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients. Surg Today 48(5):517\u2013524","journal-title":"Surg Today"},{"issue":"2","key":"2806_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.11613\/BM.2017.039","volume":"27","author":"A Desmons","year":"2017","unstructured":"Desmons A, Jaisson S, Leroy N et al (2017) Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA(1c) measurement. Biochem Med (Zagreb) 27(2):378\u2013386","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"2806_CR44","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1309\/YFVTUD0GHJF7D16H","volume":"129","author":"CL Rohlfing","year":"2008","unstructured":"Rohlfing CL, Connolly SM, England JD et al (2008) The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol 129(5):811\u2013814","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2806_CR45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.gpb.2022.11.003","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y, Wu X, Yang P et al (2022) Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis. Genomics Proteom Bioinf 20(5):850\u2013866","journal-title":"Genomics Proteom Bioinf"},{"key":"2806_CR46","doi-asserted-by":"crossref","unstructured":"Li W, Zhu L, Li K et al (2022) Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer. Nanomaterials (Basel). ;12(5)","DOI":"10.3390\/nano12050809"},{"key":"2806_CR47","doi-asserted-by":"crossref","unstructured":"Mu W, Jiang L, Shi Y et al (2021) Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET\/CT images. J Immunother Cancer. ;9(6)","DOI":"10.1136\/jitc-2020-002118"},{"issue":"5","key":"2806_CR48","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10278-021-00484-9","volume":"34","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Dong Y, Yang L et al (2021) CT-Based Hand-crafted Radiomic Signatures Can Predict PD-L1 Expression Levels in Non-small Cell Lung Cancer: a Two-Center Study. J Digit Imaging 34(5):1073\u20131085","journal-title":"J Digit Imaging"},{"issue":"5","key":"2806_CR49","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3174\/ajnr.A7488","volume":"43","author":"E George","year":"2022","unstructured":"George E, Flagg E, Chang K et al (2022) Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma. AJNR Am J Neuroradiol 43(5):675\u2013681","journal-title":"AJNR Am J Neuroradiol"},{"key":"2806_CR50","doi-asserted-by":"publisher","first-page":"745150","DOI":"10.3389\/fonc.2021.745150","volume":"11","author":"J Qian","year":"2021","unstructured":"Qian J, Wang W, Wang L et al (2021) The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus. Front Oncol 11:745150","journal-title":"Front Oncol"},{"issue":"8","key":"2806_CR51","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jtho.2017.05.010","volume":"12","author":"B Sepesi","year":"2017","unstructured":"Sepesi B, Gold KA, Correa AM et al (2017) The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer. J Thorac Oncol 12(8):1280\u20131287","journal-title":"J Thorac Oncol"},{"issue":"13","key":"2806_CR52","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1200\/JCO.2010.33.4631","volume":"30","author":"JA Sloan","year":"2012","unstructured":"Sloan JA, Zhao X, Novotny PJ et al (2012) Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol 30(13):1498\u20131504","journal-title":"J Clin Oncol"},{"issue":"4","key":"2806_CR53","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1097\/SLA.0000000000005307","volume":"277","author":"A Tang","year":"2023","unstructured":"Tang A, Ahmad U, Raja S et al (2023) How Much Delay Matters? How Time to Treatment Impacts Overall Survival in Early Stage Lung Cancer. Ann Surg 277(4):e941\u2013e7","journal-title":"Ann Surg"},{"issue":"3","key":"2806_CR54","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1016\/j.cllc.2020.05.022","volume":"22","author":"GJ Costa","year":"2021","unstructured":"Costa GJ, Silva GTD, Ferreira CG et al (2021) Brazilian Women With Lung Cancer Have a Higher Overall Survival Than Their Male Equivalents: A Cohort Study. Clin Lung Cancer 22(3):e313\u2013e9","journal-title":"Clin Lung Cancer"},{"key":"2806_CR55","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2147\/CMAR.S340334","volume":"14","author":"J Ding","year":"2022","unstructured":"Ding J, Li X, Ge J et al (2022) Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study. Cancer Manag Res 14:1313\u20131322","journal-title":"Cancer Manag Res"},{"issue":"7","key":"2806_CR56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/CM9.0000000000000739","volume":"133","author":"NF Wang","year":"2020","unstructured":"Wang NF, Tang HM, Liu FL et al (2020) Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer. Chin Med J (Engl) 133(7):786\u2013791","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2806_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/bjc.2016.141","volume":"115","author":"J Luo","year":"2016","unstructured":"Luo J, Hendryx M, Qi L et al (2016) Pre-existing diabetes and lung cancer prognosis. Br J Cancer 115(1):76\u201379","journal-title":"Br J Cancer"},{"key":"2806_CR58","doi-asserted-by":"crossref","unstructured":"Lu Y, Hu Y, Zhao Y et al (2022) Impact of type 2 diabetes mellitus on the prognosis of non-small cell lung cancer. J Clin Med. ;12(1)","DOI":"10.3390\/jcm12010321"},{"issue":"4","key":"2806_CR59","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","volume":"6","author":"G Kichenadasse","year":"2020","unstructured":"Kichenadasse G, Miners JO, Mangoni AA et al (2020) Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer. JAMA Oncol 6(4):512\u2013518","journal-title":"JAMA Oncol"},{"issue":"7","key":"2806_CR60","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/ijc.30581","volume":"140","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Xu J, Lou Y et al (2017) Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations. Int J Cancer 140(7):1645\u20131652","journal-title":"Int J Cancer"},{"issue":"6","key":"2806_CR61","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21037\/tlcr.2019.12.08","volume":"8","author":"M \u0160uti\u0107","year":"2019","unstructured":"\u0160uti\u0107 M, Motzek A, Bubanovi\u0107 G et al (2019) Promoter methylation status of ASC\/TMS1\/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC). Transl Lung Cancer Res 8(6):1000\u20131015","journal-title":"Transl Lung Cancer Res"},{"issue":"19","key":"2806_CR62","doi-asserted-by":"publisher","first-page":"7986","DOI":"10.18632\/aging.204328","volume":"14","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Wei J, Li Z et al (2022) High FHL2 mRNA expression and its prognostic value in lung cancer. Aging 14(19):7986\u20138000","journal-title":"Aging"},{"issue":"6","key":"2806_CR63","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","volume":"36","author":"M Ben Nasr","year":"2024","unstructured":"Ben Nasr M, Usuelli V, Dellepiane S et al (2024) Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule. Cell Metab 36(6):1302\u201319e12","journal-title":"Cell Metab"},{"key":"2806_CR64","doi-asserted-by":"publisher","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"Bendotti G, Montefusco L, Lunati ME et al (2022) The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists. Pharmacol Res 182:106320","journal-title":"Pharmacol Res"},{"issue":"14","key":"2806_CR65","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","volume":"29","author":"A Cortellini","year":"2023","unstructured":"Cortellini A, D\u2019Alessio A, Cleary S et al (2023) Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. Clin Cancer Res 29(14):2714\u20132724","journal-title":"Clin Cancer Res"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02806-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02806-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02806-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:30:09Z","timestamp":1791826209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02806-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":65,"alternative-id":["2806"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02806-1","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since this study is a retrospective study and patient information was anonymized at the time of data collection, patient consent was not required.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed the full text and agreed to its publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}